Reginald G.E.J. Groutars

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT

Reginald G.E.J. Groutars, J. Fred Verzijlbergen, Alinda J. Muller et al. · Journal of Nuclear Cardiology · 2000 · 48 citations

Cardiomyopathy, Cardiovascular Disease, Myocardial Infarction +8

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner et al. · Diabetes Care · 2021 · 32 citations · Full text

Incremental prognostic value of myocardial SPET with dual-isotope rest 201Tl/stress 99mTc-tetrofosmin

Reginald G.E.J. Groutars, Fred Verzijlbergen, A. H. Zwinderman et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 19 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +11